A dopamine-sensitive striatal efferent system mapped with [14C]deoxyglucose in the rat.
Rats which had exhibited contralateral rotation following unilateral injection of dopamine (DA) through a striatal cannula were given 0.5 - 50 micrograms DA intrastriatally and then were injected with [14C]deoxyglucose peripherally to measure glucose utilization in the striatum and its projection nuclei. Quantitative autoradiographic techniques were used to measure glucose utilization. Brain areas which showed L-R asymmetries and changes in glucose utilization different from vehicle-injected animals were: the substantia nigra (pars compacta and pars reticulata), the subthalamic n., entopeduncular n., lateral habenula, and deep layers of the superior colliculus. The globus pallidus was affected also, but only in one group for which the injected DA may have spread and affected it directly. Each of these areas receives projections from the striatum or is one additional synapse away. Intrastriatal injections of norepinephrine, isoproterenol, and procaine did not produce changes in glucose utilization in the striatal projection nuclei. The results support the existence of a DA-sensitive strionigral system to both the reticulata and compacta regions of the nigra, and suggest that this activity is paralleled by a strio-subthalamic and strio-entopeduncular-habenular system. The onset of changes in glucose utilization in the entopeduncular-habenular system was later than in the strio-subthalamic and strionigral systems and correlated with the onset of rotation. However, data from 4 animals which did not rotate suggest that each of these systems is necessary but not sufficient for rotation. It is concluded that DA receptors in the striatum play a significant role in the effects of peripherally administered DA agonists on other nuclei, even though most of these other nuclei also have their own DA receptors.
D000818:Animals; D001931:Brain Mapping / Q000379:methods; D003342:Corpus Striatum / Q000033:anatomy & histology* / Q000187:drug effects; D003847:Deoxyglucose / Q000378:metabolism; D004027:Diencephalon / Q000033:anatomy & histology*; D004298:Dopamine / Q000494:pharmacology*; D004525:Efferent Pathways / Q000033:anatomy & histology; D008297:Male; D008636:Mesencephalon / Q000033:anatomy & histology*; D009043:Motor Activity / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra / Q000033:anatomy & histology*
D003847:Deoxyglucose; D004298:Dopamine